StockData
Vyome Holdings, Inc logo

Vyome Holdings, Inc (HIND) stock

HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$1.45−0.06 (-3.97%)

Close on Nov 19, 2026Market cap $10.18MP/E –Yield –

Vyome free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Vyome's free cash flow for the twelve months ending Dec 31, 2023 was -$17.00M. For fiscal 2023 it was -$17.00M. The highest annual figure on record is -$8.72M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$17.00M–
FY2022Dec 31, 2022-$22.03M–
FY2021Dec 31, 2021-$15.73M–
FY2020Dec 31, 2020-$8.72M–
FY2019Dec 31, 2019-$23.06M–
FY2018Dec 31, 2018-$30.71M–
FY2017Dec 31, 2017-$31.67M–
FY2016Dec 31, 2016-$19.72M–
FY2015Dec 31, 2015-$11.53M–
FY2014Dec 31, 2014-$10.18M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023-$2.46M–
Q3 FY2023Sep 30, 2023-$2.78M–
Q2 FY2023Jun 30, 2023-$6.70M–
Q1 FY2023Mar 31, 2023-$5.07M–
Q4 FY2022Dec 31, 2022-$2.91M–
Q3 FY2022Sep 30, 2022-$5.31M–
Q2 FY2022Jun 30, 2022-$6.43M–
Q1 FY2022Mar 31, 2022-$7.39M–
Q4 FY2021Dec 31, 2021-$3.49M–
Q3 FY2021Sep 30, 2021-$7.89M–
Q2 FY2021Jun 30, 2021-$2.27M–
Q1 FY2021Mar 31, 2021-$2.08M–
Q4 FY2020Dec 31, 2020-$1.82M–
Q3 FY2020Sep 30, 2020-$976.00K–
Q2 FY2020Jun 30, 2020-$789.00K–
Q1 FY2020Mar 31, 2020-$5.14M–
Q4 FY2019Dec 31, 2019-$5.03M–
Q3 FY2019Sep 30, 2019-$4.01M–
Q2 FY2019Jun 30, 2019-$4.36M–
Q1 FY2019Mar 31, 2019-$9.66M–
Q4 FY2018Dec 31, 2018-$5.83M–
Q3 FY2018Sep 30, 2018-$5.50M–
Q2 FY2018Jun 30, 2018-$8.42M–
Q1 FY2018Mar 31, 2018-$10.96M–
Q4 FY2017Dec 31, 2017-$9.34M–
Q3 FY2017Sep 30, 2017-$7.36M–
Q2 FY2017Jun 30, 2017-$6.23M–
Q1 FY2017Mar 31, 2017-$8.73M–
Q4 FY2016Dec 31, 2016-$5.87M–
Q3 FY2016Sep 30, 2016-$5.13M–

More Vyome figures

See a number that looks wrong?